rs367881797

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001164507.2(NEB):​c.16284+11A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 65 hom., cov: 11)
Exomes 𝑓: 0.032 ( 434 hom. )

Consequence

NEB
NM_001164507.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.494

Publications

0 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 2-151581472-T-C is Benign according to our data. Variant chr2-151581472-T-C is described in ClinVar as Benign. ClinVar VariationId is 257759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0529 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.16284+11A>G intron_variant Intron 103 of 181 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.16284+11A>G intron_variant Intron 103 of 181 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.16284+11A>G intron_variant Intron 103 of 181 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.16284+11A>G intron_variant Intron 103 of 181 5 NM_001164507.2 ENSP00000416578.2 P20929-3
NEBENST00000409198.5 linkc.11602-5118A>G intron_variant Intron 78 of 149 5 ENSP00000386259.1 P20929-4
NEBENST00000413693.5 linkc.474+11A>G intron_variant Intron 3 of 73 5 ENSP00000410961.1 H0Y786

Frequencies

GnomAD3 genomes
AF:
0.0335
AC:
3175
AN:
94810
Hom.:
65
Cov.:
11
show subpopulations
Gnomad AFR
AF:
0.0484
Gnomad AMI
AF:
0.0331
Gnomad AMR
AF:
0.0214
Gnomad ASJ
AF:
0.0318
Gnomad EAS
AF:
0.00329
Gnomad SAS
AF:
0.0310
Gnomad FIN
AF:
0.0223
Gnomad MID
AF:
0.0546
Gnomad NFE
AF:
0.0316
Gnomad OTH
AF:
0.0340
GnomAD2 exomes
AF:
0.0280
AC:
3050
AN:
109098
AF XY:
0.0281
show subpopulations
Gnomad AFR exome
AF:
0.0522
Gnomad AMR exome
AF:
0.0199
Gnomad ASJ exome
AF:
0.0299
Gnomad EAS exome
AF:
0.00141
Gnomad FIN exome
AF:
0.0232
Gnomad NFE exome
AF:
0.0332
Gnomad OTH exome
AF:
0.0310
GnomAD4 exome
AF:
0.0321
AC:
20742
AN:
646124
Hom.:
434
Cov.:
9
AF XY:
0.0322
AC XY:
10840
AN XY:
336482
show subpopulations
African (AFR)
AF:
0.0559
AC:
914
AN:
16340
American (AMR)
AF:
0.0215
AC:
625
AN:
29082
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
604
AN:
18254
East Asian (EAS)
AF:
0.00248
AC:
74
AN:
29854
South Asian (SAS)
AF:
0.0312
AC:
1686
AN:
54076
European-Finnish (FIN)
AF:
0.0263
AC:
1205
AN:
45750
Middle Eastern (MID)
AF:
0.0552
AC:
133
AN:
2408
European-Non Finnish (NFE)
AF:
0.0345
AC:
14436
AN:
418484
Other (OTH)
AF:
0.0334
AC:
1065
AN:
31876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
955
1910
2864
3819
4774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0335
AC:
3183
AN:
94920
Hom.:
65
Cov.:
11
AF XY:
0.0331
AC XY:
1453
AN XY:
43856
show subpopulations
African (AFR)
AF:
0.0485
AC:
1116
AN:
23012
American (AMR)
AF:
0.0212
AC:
171
AN:
8058
Ashkenazi Jewish (ASJ)
AF:
0.0318
AC:
83
AN:
2614
East Asian (EAS)
AF:
0.00329
AC:
10
AN:
3042
South Asian (SAS)
AF:
0.0328
AC:
69
AN:
2104
European-Finnish (FIN)
AF:
0.0223
AC:
113
AN:
5060
Middle Eastern (MID)
AF:
0.0541
AC:
12
AN:
222
European-Non Finnish (NFE)
AF:
0.0316
AC:
1550
AN:
49036
Other (OTH)
AF:
0.0334
AC:
36
AN:
1078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
145
289
434
578
723
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0384
Hom.:
39
Bravo
AF:
0.0387

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.037
DANN
Benign
0.33
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367881797; hg19: chr2-152437986; API